| Financial Year |
March 31 2023 |
| Monetary Funds |
482,257,587.07 |
| Held-for-trading Financial Assets |
20,652,672.95 |
| Notes Receivable |
-- |
| Accounts Receivable |
194,586,788.99 |
| Advances to Suppliers |
34,368,151.06 |
| Other Receivables |
87,325,884.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,112,562,979.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
77,390,684.33 |
| Total Current Assets |
2,009,144,748.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
932,321,000.72 |
| Investment Properties |
305,355,812.97 |
| Fixed Assetes |
666,727,748.25 |
| Under-construction Projects |
23,599,136.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
380,108,927.69 |
| R&D expenses |
-- |
| Goodwill |
811,197,278.57 |
| Long-Term Deferred and Prepaid Expenses |
272,636,546.65 |
| Deferred Income Tax Assets |
188,530,452.45 |
| Other Non-Current Assets |
17,481,162.70 |
| Sub-Total of Non-Current Assets |
5,043,567,780.79 |
| Total Assets |
7,052,712,529.26 |
| Short-Term Loans |
791,969,285.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
219,717,685.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
43,348,585.08 |
| Taxes Payable |
43,121,493.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
533,638,879.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
62,423,649.05 |
| Other Current Liabilities |
86,806,585.87 |
| Sub-Total of Current Liabilities |
2,452,384,935.71 |
| Long-term Loans |
70,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
138,868,089.84 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
84,445,581.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
964,730,845.14 |
| Total Liabilities |
3,417,115,780.85 |
| Paid-In Capital(Or Share Stock) |
442,445,375.00 |
| Capital Surplus |
1,550,184,569.24 |
| Surplus Reserve |
144,878,881.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
819,529,704.42 |
| Minority Stockholder's Interest |
708,549,582.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,927,047,166.38 |
| Owner's Equity（Stockholder's Equity） |
3,635,596,748.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,052,712,529.26 |
